Daiichi Sankyo obtains Japanese approval for additional indication, dosage & administration of antiplatelet agent, Efient 3.75 mg &2.5 mg tablets

Daiichi Sankyo Company, Limited announced that it has obtained a supplemental new drug application approval for additional indication and dosage and administration of the antiplatelet agents